borneol Report issue

Botanical Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
Borneol is a bicyclic organic compound and a terpene derivative. The hydroxyl group in this compound is placed in an endo position. The exo diastereomer is called isoborneol. Being chiral, borneol exists as enantiomers, both of which are found in nature.   Wikipedia

Chemistry

  • SMILES: CC1(C)C2CCC1(C)C(O)C2
  • InChIKey: DTGKSKDOIYIVQL-UHFFFAOYSA-N
  • Mol. Mass: 154.25
  • ALogP: 2.19
  • ChEMBL Molecule:
    borneol  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

borneol | isoborneol | isoborneol, (1r-endo)-isomer | isoborneol, (1r-exo)-isomer | isoborneol, (1s-endo)-isomer | isoborneol, (1s-exo)-isomer | isoborneol, (endo-(+-))-isomer | isoborneol, (endo)-isomer | isoborneol, (exo)-isomer

Organizations (64)

Research & Development (64)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Altitude Sickness (Phase 3)

Angina Pectoris (Phase 3)

Angina, Stable (Early Phase 1)

Healthy Volunteers (Phase 1)

Intracranial Hemorrhages (Phase 1)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial Organizations: 64

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue